Literature DB >> 1657917

Role of alpha beta receptor heterodimer formation in beta platelet-derived growth factor (PDGF) receptor activation by PDGF-AB.

M A Heidaran1, J H Pierce, J C Yu, D Lombardi, J E Artrip, T P Fleming, A Thomason, S A Aaronson.   

Abstract

We investigated the ability of highly purified recombinant platelet-derived growth factor (PDGF) AB to interact with the products of alpha and beta receptor genes expressed in cells independently or concurrently. Although PDGF-AB lacked any detectable ability to bind or activate beta receptors in cells expressing only this receptor, efficient beta receptor activation by this ligand was readily observed in cells coexpressing alpha platelet-derived growth factor receptors (alpha PDGFRs). beta receptor activation induced by PDGF-AB was shown to be dependent upon in vivo physical association of this receptor with alpha PDGFRs. Moreover, cross-linking analysis established the existence of PDGF-AB-induced beta PDGFR dimers in vivo. All of these findings argue that initial PDGF-AB interaction with the alpha PDGFR induces conformational changes in the ligand or receptor that facilitates efficient recruitment of beta PDGFR by this PDGF isoform.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657917

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis.

Authors:  M Marx; R A Perlmutter; J A Madri
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

2.  MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.

Authors:  Yanzhi Yang; Samantha Dodbele; Thomas Park; Rainer Glass; Krishna Bhat; Erik P Sulman; Ying Zhang; Roger Abounader
Journal:  J Neurooncol       Date:  2019-09-03       Impact factor: 4.130

3.  Platelet-derived growth factor (PDGF)-AB-mediated phosphorylation of PDGF beta receptors.

Authors:  S R Coats; H D Love; W J Pledger
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

Review 4.  Pediatric de novo cerebral AVM: report of two cases and review of literature.

Authors:  Jared J Y Yeo; Sharon Y Y Low; Wan Tew Seow; David C Y Low
Journal:  Childs Nerv Syst       Date:  2014-12-24       Impact factor: 1.475

5.  Conditional deletion of platelet derived growth factor receptor alpha (Pdgfra) in urorectal mesenchyme causes mesenchyme apoptosis and urorectal developmental anomalies in mice.

Authors:  Chen Qian; Zhongluan Wu; Roy Chun-Laam Ng; Maria-Mercè Garcia-Barceló; Zheng-Wei Yuan; Kenneth Kak Yuen Wong; Paul Kwong Hang Tam; Vincent Chi Hang Lui
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

6.  Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.

Authors:  F S Vassbotn; M Andersson; B Westermark; C H Heldin; A Ostman
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

Review 7.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

Authors:  M A Soos; C E Field; K Siddle
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

9.  Two ligands signal through the Drosophila PDGF/VEGF receptor to ensure proper salivary gland positioning.

Authors:  Katherine E Harris; Nikolai Schnittke; Steven K Beckendorf
Journal:  Mech Dev       Date:  2007-03-13       Impact factor: 1.882

10.  Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure.

Authors:  Ryan McMillan; Leonidas Skiadopoulos; Debra Hoppensteadt; Nil Guler; Vinod Bansal; Ravipresenna Parasuraman; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2017-10-08       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.